The global market for tardive dyskinesia treatment is witnessing significant development. This phenomenon is driven by a increasing prevalence of tardive dyskinesia, coupled with progresses in treatment approaches. The market is segmented by various variables, including drug types, marketing strategies, and locations. Key stakeholders in the arena